AIM: To quantify structural and functional degeneration in the retinal nerve fibre layer (RNFL) of patients with multiple sclerosis (MS) over a 2-year time period, and to analyse the effect of prior optic neuritis (ON) as well as the duration and incidence of MS relapses. METHODS: 166 MS patients and 120 healthy controls underwent assessment of visual acuity and colour vision, visual field examination, optical coherence tomography, scanning laser polarimetry and visual evoked potentials (VEPs). All subjects were re-evaluated after a period of 12 and 24 months. RESULTS: Changes in the optic nerve were detected by structural measurements but not by functional assessments. Changes registered in MS patients were greater than changes in healthy controls (p<0.05). Eyes with previous ON showed a greater reduction of parameters in the baseline evaluation, but RNFL atrophy was not significantly greater in the longitudinal study. Patients with MS relapses showed a greater reduction of RNFL thickness and VEP amplitude compared with non-relapsing cases. Patients with and without treatment showed similar measurement reduction, but the non-treated group had a significantly higher increase in Expanded Disability Status Scale (p=0.029). CONCLUSIONS: MS causes progressive axonal loss in the optic nerve, regardless of a history of ON. This ganglion cell atrophy occurs in all eyes but is more marked in MS eyes than in healthy eyes.
AIM: To quantify structural and functional degeneration in the retinal nerve fibre layer (RNFL) of patients with multiple sclerosis (MS) over a 2-year time period, and to analyse the effect of prior optic neuritis (ON) as well as the duration and incidence of MS relapses. METHODS: 166 MS patients and 120 healthy controls underwent assessment of visual acuity and colour vision, visual field examination, optical coherence tomography, scanning laser polarimetry and visual evoked potentials (VEPs). All subjects were re-evaluated after a period of 12 and 24 months. RESULTS: Changes in the optic nerve were detected by structural measurements but not by functional assessments. Changes registered in MS patients were greater than changes in healthy controls (p<0.05). Eyes with previous ON showed a greater reduction of parameters in the baseline evaluation, but RNFL atrophy was not significantly greater in the longitudinal study. Patients with MS relapses showed a greater reduction of RNFL thickness and VEP amplitude compared with non-relapsing cases. Patients with and without treatment showed similar measurement reduction, but the non-treated group had a significantly higher increase in Expanded Disability Status Scale (p=0.029). CONCLUSIONS: MS causes progressive axonal loss in the optic nerve, regardless of a history of ON. This ganglion cell atrophy occurs in all eyes but is more marked in MS eyes than in healthy eyes.
Authors: Anna M Pietroboni; Tiziana Carandini; Laura Dell'Arti; Francesca Bovis; Annalisa Colombi; Milena A De Riz; Elena Casazza; Elisa Scola; Chiara Fenoglio; Andrea Arighi; Giorgio G Fumagalli; Fabio Triulzi; Daniela Galimberti; Francesco Viola; Elio Scarpini Journal: Neurol Sci Date: 2020-04-30 Impact factor: 3.307
Authors: Divya Narayanan; Han Cheng; Karlie N Bonem; Roberto Saenz; Rosa A Tang; Laura J Frishman Journal: Mult Scler Date: 2014-03-17 Impact factor: 6.312
Authors: John N Ratchford; Shiv Saidha; Elias S Sotirchos; Jiwon A Oh; Michaela A Seigo; Christopher Eckstein; Mary K Durbin; Jonathan D Oakley; Scott A Meyer; Amy Conger; Teresa C Frohman; Scott D Newsome; Laura J Balcer; Elliot M Frohman; Peter A Calabresi Journal: Neurology Date: 2013-01-01 Impact factor: 9.910
Authors: V Polo; E Garcia-Martin; M P Bambo; J Pinilla; J M Larrosa; M Satue; S Otin; L E Pablo Journal: Eye (Lond) Date: 2014-03-14 Impact factor: 3.775
Authors: Amir H Kashani; Samuel Asanad; Jane W Chan; Maxwell B Singer; Jiong Zhang; Mona Sharifi; Maziyar M Khansari; Farzan Abdolahi; Yonggang Shi; Alessandro Biffi; Helena Chui; John M Ringman Journal: Prog Retin Eye Res Date: 2021-01-15 Impact factor: 19.704
Authors: Maria Satue; Javier Obis; Maria J Rodrigo; Sofia Otin; Maria I Fuertes; Elisa Vilades; Hector Gracia; Jose R Ara; Raquel Alarcia; Vicente Polo; Jose M Larrosa; Luis E Pablo; Elena Garcia-Martin Journal: J Ophthalmol Date: 2016-10-20 Impact factor: 1.909
Authors: Elena Garcia-Martin; Javier Garcia-Campayo; Marta Puebla-Guedea; Francisco J Ascaso; Miguel Roca; Fernando Gutierrez-Ruiz; Elisa Vilades; Vicente Polo; Jose M Larrosa; Luis E Pablo; Maria Satue Journal: PLoS One Date: 2016-09-01 Impact factor: 3.240